Nimbus partners with Lilly on novel obesity treatment
Drug discovery company Nimbus Therapeutics has partnered with Eli Lilly to develop a novel oral treatment for obesity and other metabolic diseases. The companies aim to apply Nimbus’ computational chemistry and structure-based drug design approach to an early-stage, small molecule discovery programme addressing a significant unmet need… Read More
